The global implantable medical devices market is expected to grow with a compound annual growth rate of 7.45 percent between 2016 and 2023, Occams Business Research and Consulting reports.
Here are the major players in the implantable medical devices market, according to the report. Note: companies are listed in alphabetical order.
Abbott Park, Ill.-based Abbott Laboratories is a global healthcare company in the cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition and pharmaceuticals markets. Abbott Laboratories reported revenue for the fourth quarter of 2017 rose 42.3 percent to $7.6 billion, up from $5.3 billion in 2016.
Global medical devices manufacturer Marlborough, Mass.-based Boston Scientific Corp. develops products used in a range of interventional medical specialties including urology, interventional radiology, gastroenterology, vascular surgery and orthopedic surgery, among others. Boston Scientific reported sales of $2.22 billion for the third quarter of 2017, a growth of 5.7 percent on an operational basis compared to the prior year period.
Dublin, Ohio-based Cardinal Health is a Fortune 500 global integrated healthcare services and products company in the skin and wound management, durable medical equipment, home healthcare and pharmaceuticals markets, among others. Cardinal Health reported fourth quarter fiscal year 2017 revenues of $33 billion, an increase of 5 percent from the fourth quarter in the prior year and full year 2017 revenues of $130 billion, an increase of 7 percent from the same period last year.
Audubon, Pa.-based Globus Medical is a spine implant manufacturer with a product line of over 100 spine products including those used for minimally invasive spine techniques and the treatment of scoliosis. Globus Medical reported sales of $151.7 million for the third quarter of 2017, an increase of 11.9 percent from the prior year period.
Global surgical instrument manufacturing company Integra Lifesciences Holdings Corp. in Plainsboro, N.J., is involved in the surgical reconstruction, orthopedics, surgical lighting, dural repair, brain retraction and neurocritical care markets, among others. Integra Lifesciences reported third quarter revenue for fiscal year 2017 increased 11.4 percent to $278.8 million over the same quarter in the prior year while organic revenue increased 1.5 percent.
Multinational New Brunswick, N.J.-based pharmaceutical company Johnson & Johnson is involved in the immunology, cardiovascular and metabolic disease, pulmonary hypertension, vaccinations, oncology, wound care and surgical devices markets, among others. Additionally, Johnson & Johnson encompasses DePuy Synthes, which provides orthopedic surgical and neurosurgical solutions. Johnson & Johnson reported 2017 fourth quarter sales of $20.2 billion, an increase of 6.3 percent from the same period in the previous year.
London, England-based medical device manufacturer LivaNova specializes in the cardiac surgery, neuromodulation and cardiac rhythm management markets. The company has strategic portfolio initiatives in vagus nerve stimulation for treatment-resistant depression, transcatheter mitral valve replacement and Vitaria VNS therapy treatment for heart failure. LivaNova reported worldwide sales of $309.7 million for the third quarter of 2017, an increase of 4.9 percent as compared to the same quarter of the previous year.
Innsbruck, Austria-based hearing implant company Med-El is in the cochlear implant, middle ear implant, electric acoustic stimulation and sports headband markets, and produces other assistive listening technologies as well. Prelingually and postlingually deafened and hearing impaired adults and children use Med-El's products. Med-El offers rehabilitation support to its hearing implant recipients and developed free interactive rehabilitation listening apps and resources.
Medtronic is a medical device company headquartered in Dublin, Ireland, with an operational headquarters in Minneapolis. Medtronic is in the cardiac rhythm, cardiovascular, spine and orthopedic, diabetes and pain management market, among others. The company reported fourth quarter worldwide 2017 revenue of $7.9 billion, compared to $7.5 billion reported in the fourth quarter of 2016 and an increase of 5 percent on both a reported and constant currency basis.
San Diego-based NuVasive is a spine surgery technology company in the orthopedics, advanced materials science, biologics and limb lengthening markets, among others. The NuVasive-sponsored SpineTRACK Registry is a data collection platform for patient-reported and clinical outcomes of patients with spinal disease; the information is kept in a HIPAA-compliant and secure site. NuVasive reported third quarter 2017 revenue of $274.4 million, a 3.2 percent increase compared to $239.6 million for the third quarter 2016.
London, England-based multinational medical equipment manufacturer Smith & Nephew is in the advanced wound management, orthopedic reconstruction, sports medicine and robotic-assisted surgery markets, among others. Smith & Nephew reported third quarter 2017 revenue of $1.152 billion, up 3 percent on both a reported and underlying basis from the same period in 2016.
Stäfa, Switzerland-based Sonova Holding is a hearing loss supports company in the hearing aids and cochlear implants markets. Sonova operates Phonak, Unitron, Hansatron, Advanced Bionics and AudioNova. The company reported that consolidated sales increased 16.9 percent in local currencies to $1.33 billion for the first half of fiscal year 2017-18.
Kalamazoo, Mich.-based Stryker Corp. is a medical technology company in the orthopedic, neurotechnology and spine markets, among others. Stryker is a Fortune 500 company founded by orthopedic surgeon Homer Stryker, MD, in 1941. The company now employs over 33,000 people worldwide. Stryker reported third quarter 2017 net sales growth of 6.1 percent as reported and 5.8 percent in constant currency to $3 billion.
Memphis, Tenn.-based Wright Medical Group is a global medical device company in the upper and lower extremities and biologics markets. It is internationally headquartered in Middlesex in the United Kingdom. Wright Medical Group reported third quarter 2017 net sales of $170.5 million.
Warsaw, Ind.-based medical device company Zimmer Biomet is in the sports medicine, orthopedic trauma, cement, diagnostics, bone healing and limb salvage market, among others. Zimmer Biomet reported third quarter 2017 net sales of $1.8 billion, a 0.8 percent decrease from the prior year period. Zimmer Biomet acquired French robot-assisted surgery company Medtech SA in 2016.
More articles on supply chain:
Allergan expected to post EPS of $4.73 for 2017 — 3 insights
Valeant to pay down $200 million in debt — 4 insights
McKesson to close New Jersey distribution center, lay off 102 employees — 3 insights